ReviewIndian journal of sexually transmitted diseases and AIDS
Human papillomavirus vaccine use in clinical practice - What dermatologists should know as health care providers.
Review in Indian journal of sexually transmitted diseases and AIDS. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Impact of an Educational Intervention Video in HPV Prevention among Tunisian Female Students: A before-and-after Study.Journal of preventive medicine and hygiene · 2025Article
- Erratum: Human papillomavirus vaccine use in clinical practice - What dermatologists should know as health care providers.Indian journal of sexually transmitted diseases and AIDSArticle
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human papillomavirus (HPV) infection is considered to be the most common sexually transmitted disease among both males and females, with an incidence of 14% in South-East Asia. Cervical cancer is one of the most prevalent types of cancer over the past years and the 3rd main cause of cancer-related mortality among adults. There is consensus that persistent high-risk HPV infection is necessary to cause cervical cancer. Vaccination is the best way to prevent HPV infection. Currently, bivalent, quadrivalent, and nonavalent vaccines are available. In this narrative review, information about different diseases caused by human papillomaviruses, role of HPV vaccines in prevention, and their role in the therapy of recalcitrant warts has been discussed. A systematic search of various databases and search engines such as Medline, PubMed, Embase, Scopus, Cochrane Library, and Science Direct was done. HPV vaccines play a preventive role against the HPV types present in the vaccine. Vaccinating girls and boys before sexual debut is anticipated to maximize disease control. The role of vaccines in older women is under evaluation. The role of HPV vaccines as therapeutic modality in recalcitrant warts has also been explored with encouraging results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.